Faes Farma targets to double sales and EBITDA by 2030, driven by international expansion, M&A, and increased R&D investment. The 2025–2030 plan focuses on innovation, operational excellence, and sustainability, with a strong push in ophthalmology and animal nutrition.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.